U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC that are being simultaneously presented at the American Heart ...

Jim Gaffigan has struggled with his weight for most of his adult life, but it seems that his most recent 50-lb weight loss is ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Changes to the structure of DNA within fat cells may be why it is often so hard to keep weight off after you have lost it ...